CLINICAL_TRIALS
trial_result
· 2016-10-03
Clinical Trial Update: Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia [Phase 1]
Summary
Phase 1 study evaluating roflumilast in combination with antipsychotics in schizophrenia; results from the proof-of-mechanism trial have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2016-10-03